
Research Solutions Inc. (NASDAQ:RSSS - Free Report) - Investment analysts at Roth Capital increased their FY2025 earnings per share (EPS) estimates for Research Solutions in a report issued on Tuesday, August 19th. Roth Capital analyst R. Baldry now forecasts that the company will post earnings per share of $0.07 for the year, up from their prior forecast of $0.05. The consensus estimate for Research Solutions' current full-year earnings is $0.05 per share. Roth Capital also issued estimates for Research Solutions' Q4 2025 earnings at $0.02 EPS.
Research Solutions Stock Up 2.5%
RSSS stock traded up $0.08 during trading on Friday, hitting $3.11. The company had a trading volume of 37,548 shares, compared to its average volume of 81,168. The firm has a 50-day moving average price of $2.81 and a 200-day moving average price of $2.84. Research Solutions has a 12 month low of $2.32 and a 12 month high of $4.24. The stock has a market cap of $100.79 million, a price-to-earnings ratio of -22.18, a PEG ratio of 3.28 and a beta of 0.67.
Institutional Trading of Research Solutions
Institutional investors have recently bought and sold shares of the business. Northern Trust Corp lifted its position in Research Solutions by 13.2% in the 4th quarter. Northern Trust Corp now owns 42,706 shares of the company's stock valued at $177,000 after acquiring an additional 4,989 shares in the last quarter. Evernest Financial Advisors LLC bought a new stake in Research Solutions in the 2nd quarter valued at $35,000. Cubist Systematic Strategies LLC bought a new stake in Research Solutions in the 4th quarter valued at $56,000. Schonfeld Strategic Advisors LLC bought a new stake in Research Solutions in the 4th quarter valued at $62,000. Finally, Millennium Management LLC bought a new stake in Research Solutions in the 4th quarter valued at $65,000. Institutional investors and hedge funds own 33.60% of the company's stock.
About Research Solutions
(
Get Free Report)
Research Solutions, Inc, through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer's internal datasets.
Featured Stories

Before you consider Research Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Research Solutions wasn't on the list.
While Research Solutions currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.